Clinical Trials List
2024-10-01 - 2029-09-30
Phase III
Recruiting6
ICD-10C61
Malignant neoplasm of prostate
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9185
Malignant neoplasm of prostate
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Cheng-Che Chen Division of Urology
- 張瓈文 Division of Urology
- Cheng-Kuang Yang Division of Urology
- 蔡世傳 Division of Urology
- Chia-Yen Lin Division of Urology
- 王樹吉 Division of Urology
- 楊涵中 Division of Urology
- 楊哲瑞 Division of Urology
- Shian-Shiang Wang Division of Urology
- 洪晟鈞 Division of Urology
- 梅承恩 Division of Urology
- 廖博崎 Division of Urology
- 張家程 Division of Urology
- Jian-Ri Li Division of Urology
- JU-CHUAN HU Division of Urology
- 裘坤元 Division of Urology
- 林雁婷
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- JIAN-HUA HONG Division of Urology
- Ying-Chun Shen Division of Urology
- YEN-HENG LIN Division of Urology
- 張尚仁 Division of Urology
- PO-MING CHOW Division of Urology
- - - Division of Urology
- Yeong-Shiau Pu Division of Urology
- 王中傑 Division of Urology
- FU-JEN HSUEH Division of Urology
- CHING-CHU LU Division of Urology
- YU-CHUAN LU Division of Urology
- 闕士傑 Division of Urology
- Yu-Chieh Tsai Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 阮雍順 Division of Urology
- Wen-Jeng Wu Division of Urology
- 張顥瀚 Division of Urology
- Ching-Chia Li Division of Urology
- 李明儒 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tzu-chun Wei Division of Urology
- Yen-Hwa Chang Division of Urology
- I-Shen Huang Division of Urology
- Chih-Chieh Lin Division of Urology
- 賴谷順 Division of Urology
- 陳威任 Division of Urology
- Tzu-Ping Lin Division of Urology
- Jia-An Hong Division of Urology
- William Huang Division of Urology
- Tzu-Hao Huang Division of Urology
- Yi-Hsiu Huang Division of Urology
- 蔡承翰 Division of Urology
- Chien-Hsin Ting Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張境夫 Division of Hematology & Oncology
- 吳俊德 Division of Hematology & Oncology
- I-hung Shao Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- Kai-Jie Yu Division of Hematology & Oncology
- 黃亮鋼 Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
- 余紹銘
- PO-HUNG LIN Division of Hematology & Oncology
- 沈鼎文 Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
- See-Tong Pang Division of Hematology & Oncology
- Hong-Cheng Gan Division of Hematology & Oncology
- Feng-Yuan Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 鍾秉軒 Division of Hematology & Oncology
- Che-Yuan Hu Division of Hematology & Oncology
- Yuh-Shyan Tsai Division of Hematology & Oncology
- Jiann-Hui Ou Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
600 participants
